KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer.

Saved in:
Bibliographic Details
Title: KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer.
Authors: Wei Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liu M; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yen EY; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas., Yao J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Xun Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nguyen PT; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas., Wang X; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang Z; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yousef A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pan D; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jin Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Li CF; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Theardy MS; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Park J; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cai Y; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas., Takeda M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vasquez M; Systems Medicine and Bioengineering Department, Houston Methodist Cancer Center, Houston, Texas., Park EM; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Peng DH; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhou Y; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas., Zhao H; Systems Medicine and Bioengineering Department, Houston Methodist Cancer Center, Houston, Texas., Heffernan TP; Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION) Platform, Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas., Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas., Wang H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Watowich SS; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Liang H; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate Program in Quantitative and Computational Biosciences, Baylor College of Medicine, Houston, Texas.; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhao D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., DePinho RA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yao W; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ying H; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center and University of Texas Health Science Center, Houston, Texas.
Source: Cancer research [Cancer Res] 2025 Dec 01; Vol. 85 (23), pp. 4825-4838.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-25-2024